Package 70436-123-31

{"route": ["INTRAVENOUS"], "spl_id": "32f1536f-eb01-305c-e063-6294a90a1855", "openfda": {"unii": ["L0ND3981AG"], "spl_set_id": ["85404ca7-dbe7-4d06-b30c-4368dcd33b0b"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (70436-123-31)  / 5 mL in 1 VIAL", "package_ndc": "70436-123-31", "marketing_start_date": "20240628"}, {"sample": false, "description": "10 VIAL in 1 CARTON (70436-123-33)  / 10 mL in 1 VIAL", "package_ndc": "70436-123-33", "marketing_start_date": "20240628"}, {"sample": false, "description": "10 VIAL in 1 CARTON (70436-123-34)  / 15 mL in 1 VIAL", "package_ndc": "70436-123-34", "marketing_start_date": "20240628"}, {"sample": false, "description": "10 VIAL in 1 CARTON (70436-123-35)  / 20 mL in 1 VIAL", "package_ndc": "70436-123-35", "marketing_start_date": "20240628"}], "brand_name": "gadoterate meglumine", "product_id": "70436-123_32f1536f-eb01-305c-e063-6294a90a1855", "dosage_form": "INJECTION", "pharm_class": ["Gadolinium-based Contrast Agent [EPC]", "Magnetic Resonance Contrast Activity [MoA]"], "product_ndc": "70436-123", "generic_name": "gadoterate meglumine", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "gadoterate meglumine", "active_ingredients": [{"name": "GADOTERATE MEGLUMINE", "strength": "376.9 mg/mL"}], "application_number": "ANDA218073", "marketing_category": "ANDA", "marketing_start_date": "20240628", "listing_expiration_date": "20261231"}